Illustration of the ACURATE neo2 Aortic Valve System in anatomy. Supra-annular TAVI. Illustration of the ACURATE neo2 Aortic Valve System in anatomy. Supra-annular TAVI.

Clinical data

Early neo2 Registry core-lab results

First large, real-world clinical data on the ACURATE neo2™ Aortic Valve System*: The Early neo2 Registry

Independently studying 85% of the original study’s 554 patients, the Early neo2 Registry core-lab analysis confirmed minimized paravalvular leak rates with the ACURATE neo2 Valve and its Active PVsealTM  sealing skirt.

heart icon

6.0%

new permanent pacemaker

drop icon

2.7%

moderate to severe PVL1

line icon

8.0mmHg

mean gradient

1. Möllmann H, Holzhey DM, Hilker M, et al. The ACURATE neo2 valve system for transcatheter aortic valve implantation: 30-day and 1-year outcomes. Clin Res Cardiol. 2021;110(12):1912–1920.

See presentation replay

COMALIGN Study

First real-world analysis of patient-specific implantation techniques using different devices. The COMALIGN study demonstrated that neo-commissural alignment and optimized valve design can improve procedural success.

Best-in-class commissural alignment: ACURATE neo2 was the only self-expanding valve to 100% avoid commissural misalignment.2

2. Bieliauskas G, Wong I, Bajoras V, et al. Patient-specific implantation technique to obtain neo-commissural alignment with self-expanding transcatheter aortic valves. J Am Coll Cardiol 2021;14(19):2097-2108.
0% moderate or severe commissural misalignment
 ACURATE neo2 Valve

0% moderate or severe commissural misalignment
ACURATE neo2 Valve

20/20 successful consecutive cases

10% moderate or severe commissural misalignment 
Evolut R™/PRO Valve

10% moderate or severe commissural misalignment
Evolut™ R/PRO Valve

17/20 successful consecutive cases; 3 cases with non-optimal rotations

25% moderate or severe commissural misalignment 
PORTICO™ Valve

25% moderate or severe commissural misalignment
PORTICO™ Valve

15/20 successful consecutive cases; 5 cases difficult to assess

RE-ACCESS Study

First systematically evaluated analysis of coronary access before and after TAVI in an all-comers’ population

With 0 incidences of unsuccessful coronary cannulation, ACURATE neo demonstrated an extremely high coronary access success rate.

100%

ACURATE neo™ Valve Platform

100% successful coronary cannulation
n = 723

82%

Evolut™ R/PRO

82% successful coronary cannulation
n = 1233

99%

SAPIEN Platform

99% successful coronary cannulation
n = 963

3. Reobtain Coronary Ostia Cannulation Beyond Transcatheter Aortic Valve Stent (RE-ACCESS); NCT04026204 J Am Coll Cardiol Intv. 2020.

1. Möllmann H, Holzhey DM, Hilker M, et al. The ACURATE neo2 valve system for transcatheter aortic valve implantation: 30-day and 1-year outcomes. Clin Res Cardiol. 2021;110(12):1912–1920.

2. Bieliauskas G, Wong I, Bajoras V, et al. Patient-specific implantation technique to obtain neo-commissural alignment with self-expanding transcatheter aortic valves. J Am Coll Cardiol 2021;14(19):2097-2108.

3. Reobtain Coronary Ostia Cannulation Beyond Transcatheter Aortic Valve Stent (RE-ACCESS); NCT04026204. J Am Coll Cardiol Intv. 2020.

Caution: The law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings and instructions of use can be found in the product labeling supplied with each device. Information for the use only in countries with applicable health authority product registrations. The information presented in this document by Boston Scientific is intended for healthcare professionals in India. [The information presented in this document is intended to provide balanced, scientific, and evidence-based answers to unsolicited medical questions.] The information should not be, however, treated as comprehensive and does not intend to provide diagnosis, treatment or any medical or health advice. For full information about the product, please refer to the appropriate product labeling. Responsibility for patient care resides with the healthcare professional on the basis of his or her professional license, experience and knowledge of the patient. Healthcare professionals must rely on their judgment when deciding which treatments and procedures to use with patients.